NIAID studies of interleukin-2. National Institute of Allergy and Infectious Diseases.
Folkers
G
G
D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000150:complications / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha